vialroom

#semaglutide 2026-06-30

Tuesday73 messages12 participantstimes are UTC
Highlights from this day
  • freya_fridge — restarted after 10 months off at a low dose and the nausea arrived exactly like the first time 21:06
  • relabel_watch — right so moving my dose day by a day or two never did anything noticeable for me the plateau hit me at 5 weeks and moved again about a month later without a dose change 21:21
  • freya_fridge — compounded and brand felt the same to me at 10, which is one person and nothing more 22:46
BB

what did SELECT actually measure, i see it quoted for everything

🙏11

anyone compared their 2.5 vial dosing against the pen increments

[edited]
EE

anyone gone from 7.5 straight to 2.5 or is that too big a jump

does the licensed ceiling for weight differ from the diabetes one

🔥12

my dose day drifted from friday to sunday, does that reset anything

went too fast once

BB

does anyone actually run a five week step instead of four

BF

STEP is several trials, so saying STEP said x is usually wrong without a number after it, someone check my working

FF

i dont think the plateau is a dose problem most of the time, but i cant prove that

RW

quick one going slow cost me nothing except time and saved me two bad weeks, thats my whole contribution

vial units and pen clicks are different systems, mixing the two is how people end up wrong

FF

steady state takes weeks

Trial scheduleWhat most people here do
Step interval4 weeks, fixed4-12 weeks, on symptoms
Holdingprotocol deviationnormal and expected
Top dosereached by designoften never reached
Coming downnot studiedcommon at maintenance

give it four weeks

⚠️5

went 1 to 1.7 too fast and spent two weeks regretting it, dropped back and repeated the step

[edited]
FF

im 6 months in at 2 and the appetite effect faded, is that a thing

Cited study
Effects of Semaglutide on Chronic Kidney Disease in Type 2 Diabetes (FLOW)
New England Journal of Medicine · 2024
Renal outcomes. The one that changed a lot of nephrologists’ minds.
TT

how long till steady state, ive read the half life is about a week

did anyone titrate slower than four weeks a step and how did that go

does moving my dose day by two days matter with a seven day half life

Cited study
Tirzepatide versus Semaglutide Once Weekly in Type 2 Diabetes (SURPASS-2)
New England Journal of Medicine · 2021
The head-to-head everyone quotes. Note the semaglutide comparator dose.

STEP 1 ran to 68 weeks. thats the one everyone half remembers

STEP 4 had the withdrawal arm, thats the one people quote when they talk about stopping

restarted after 10 months off at a low dose and the nausea arrived exactly like the first time

😂4🧪8⚠️15
RR

my 2 vial in 3ml gives 10mg/ml so 15 lands on 20 units, thats why i picked that volume, from memory

TT

my plateau was the scale stopping while appetite stayed suppressed, which is a different problem, your mileage will differ

did anyone hold at 15 longer than four weeks before going up

⚠️15👍1

*VendorInvestigate not the other one

RW

right so moving my dose day by a day or two never did anything noticeable for me
the plateau hit me at 5 weeks and moved again about a month later without a dose change

🎉1💀11
RW

the long half life flattens the trough more than people expect, i never felt a day seven dip

chromatogram-overlay.png
1240 × 720 · 935 KB · not retained in the public archive

2.4 is the ceiling

HL

14 months at 2.4 and the honest summary is diminishing returns after the first half

JJ

i stayed on 1.7 for 6 months and never went to 2.4, appetite was already where i needed it

HL

dose day is sunday for me only because thats when i remember, not because sunday matters

🧪1🎉6
JJ

quick one licensed ceiling for weight is 2.4 weekly, anything above that is not a licensed dose

SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial

vials not pens here

BF

coming back to this the trials titrated on a fixed schedule, most people here dont, worth remembering when comparing

whats the actual licensed ceiling, i keep seeing different numbers

MP

is there a reason to hold at 1.7 rather than going to 2.4

slower worked better

RR

is the plateau at 22 weeks normal or am i doing something wrong

JJ

changed my mind on the four week rule, i think it depends entirely on how the current dose feels

TT

how long did the first 20kg take for people at the low doses

BF

steady state is the bit people skip, judging a new dose after eight days tells you almost nothing

TT

the appetite effect faded for me around 9 months and going up fixed it for a while

i was wrong about the ceiling for a year, i thought 3 existed. it doesnt for the weight indication, thats just me

FF

compounded and brand felt the same to me at 10, which is one person and nothing more

📈1111🎉1

was SELECT the one that ran to 68 weeks or am i mixing them up

back after 17 months off, do i restart at 0.25 or somewhere higher

HL

quick one held at 2.5 and lost 77lb over 23 months, slower than the trials and fine by me
went to 2.4 and the extra suppression wasnt worth the GI for me, so i came back down

how many weeks before you noticed anything at 15

FF

$38 a month for compounded against what brand costs locally is why most people here use vials

EE

FLOW was the kidney outcomes trial and it gets quoted in here for things it didnt measure

went to 2.4 and the extra suppression wasnt worth the GI for me, so i came back down

did anybody find a difference between Homopeptide and pharmacy at the same 15

*Medutest not the other one

lost about 39kg on the low doses before i even got to 1, which surprised me, thats one data point